fbpx

E-Newsletter: February 5, 2020

Hello,

Welcome back to Alzheimer‘s Research News You Can Use. As we kickoff our bi-weekly schedule for the year, we encourage you to remain steadfast with your 2020 goals. It is only with repetition do we truly form habits.

In this week’s edition, we discuss some promising treatments for those living with Alzheimer’s disease. In our first article, drug company Biogen is working towards the approval of a drug that can help people in the early stages of Alzheimer’s disease. Our second article discusses how light exposure can help those living with Alzheimer’s. To learn about both studies, check out the expert-reviewed articles below.

Thank you for your interest in learning more about the research progress being made at the Fisher Center.

For up-to-date information about Alzheimer’s, visit our website at www.alzinfo.org.

Together we can end Alzheimer’s.

Sincerely,

Lucretia Holden, SHRM-CP
Executive Director

Research Articles

Drug Company to Pursue Approval of Aducanumab, New Drug for Alzheimer’s

January 15, 2020

The drug company Biogen is seeking approval for an experimental Read More

Elderly - light therapy

How Light May Help People with Alzheimer’s Disease

January 13, 2020

Exposure to bright light may improve sleep and ease depression Read More

We consistently receive top awards and ratings for our accountability: